1·Long-term overuse of alcohol, for example, can cause alcoholic hepatitis.
例如，长期嗜酒会引起酒精性肝炎。
2·A histologic scoring system for prognosis of patients with alcoholic hepatitis.
【译】组织学评分系统对酒精性肝炎患者的预后。
3·Methods Carry on retrospective analysis research to the sufferer's clinical data of 72 cases alcoholic hepatitis.
方法对72例酒精性肝炎患者的临床资料进行回顾性分析研究。
4·The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids.
里尔模型： 类固醇为重度酒精性肝炎患者的治疗策略的新工具。
5·Hepatology Digest: Will you please give us your general over-view of the current progress in the treatment of alcoholic hepatitis?
国际肝病：您能给我们概括介绍一下目前治疗酒精性肝炎的进展吗？
6·Research results found a significantly higher rate of six-month mortality in patients with moderate to severe alcoholic hepatitis who received etanercept.
研究结果发现接受依那西普的中重度酒精性肝炎患者的六个月死亡率显著增高。
7·Alcoholic hepatitis is a serious liver disease that may lead to cirrhosis and carcinoma, and the short-term mortality rate is fairly high in severe patients.
酒精性肝炎往往导致肝硬化及肝癌，其重症患者短期死亡率相当高。
8·Several research studies have worked to find a successful treatment for alcoholic hepatitis, but no consensus has been reached on the most effective treatment regimen.
已经有一些研究发现了治疗酒精性肝炎成功的治疗方法，但是在最有效的治疗的用药方法上还没有达成一致的意见。
9·Despite this treatment, 30-35% of patients with acute alcoholic hepatitis still die within a six month period, since the cortisone-based treatment remains insufficient.
尽管这种治疗方法，但仍有30 - 35%的急性酒精性肝炎患者死于六个月内，因为可的松为基础的治疗仍然效果不足。
10·Hepatology Digest: Recently, the clinical trial result for the use of Etanercept for alcoholic hepatitis was published in Gastroenterology, and you were one of the authors.
国际肝病：最近在胃肠病学杂志上发表了酒精性肝炎使用依那西普的临床试验结果，您是作者之一。